FDA Approves New Treatment Option for Patients with ALS
http://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-option-patients-als

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/golden-state-medical-supply-inc-issues-voluntary-nationwide-recall-atenolol-25-mg-tablets-and

FDA, Veterans Health Administration Collaborate to Help Accelerate Medical Device Innovation and Advancement of Care
http://www.fda.gov/news-events/press-announcements/fda-veterans-health-administration-collaborate-help-accelerate-medical-device-innovation-and

FDA Proposes Updated Definition of ‘Healthy’ Claim on Food Packages to Help Improve Diet, Reduce Chronic Disease
http://www.fda.gov/news-events/press-announcements/fda-proposes-updated-definition-healthy-claim-food-packages-help-improve-diet-reduce-chronic-disease

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/proper-trade-llcmy-stellar-lifestyle-issues-voluntary-nationwide-recall-wonder-pill-capsules-due

FDA Roundup: September 27, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-september-27-2022

Coronavirus (COVID-19) Update: FDA Updates COVID-19 Test Policy, Encourages Developers to Seek Traditional Premarket Review for Most Test Types
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-updates-covid-19-test-policy-encourages-developers-seek-traditional

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/eugia-us-llc-issues-voluntary-nationwide-recall-acyclovir-sodium-injection-500-mg-10-ml-50-mgml-due

FDA Roundup: September 23, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-september-23-2022

New FDA Draft Guidance Aims to Protect Children who Participate in Clinical Trials
http://www.fda.gov/news-events/press-announcements/new-fda-draft-guidance-aims-protect-children-who-participate-clinical-trials